Medium impact
[Georgia] April 2026 Pharmacy Policy Updates (6/6)
CareSource·Effective May 1, 2026
HCPCS J7313 is officially defined as "Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg." HCPCS J7313 is referenced in 1 tracked payer policy change from CareSource. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J7313 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.